FDA recall D-0735-2021
Teva Pharmaceuticals USA · Class II · drug
Product
Vecuronium Bromide for Injection 10 mg, 10mL vial, Rx only, Teva Pharmaceuticals USA, North Wales, PA 19454, NDC 0703-2914-01
Reason for recall
Lack of Assurance of Sterility
Distribution
Product was distributed Nationwide, including Puerto Rico.
Key facts
- Status
- Terminated
- Initiation date
- 2021-07-29
- Report date
- 2021-08-25
- Termination date
- 2024-06-04
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Parsippany, NJ, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0735-2021